Net Loss Per Share

12 Months Ended

Dec. 31, 2017

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share

12.

Net Loss Per Share

Basic net loss per common share is computed by dividing net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the periods. Fully diluted net loss per common share is computed using the weighted average number of common and dilutive common equivalent shares outstanding during the periods. Common equivalent shares consist of stock options and warrants that are computed using the treasury stock method.

For the years ended December 31, 2017 and 2016, all of the Company’s common stock options and warrants are anti-dilutive and therefore have been excluded from the diluted calculation.

The following table reconciles net loss to net loss attributable to Heat Biologics, Inc.:

	For the years ended December 31,
	2017			2016
Net loss	$	(12,409,866	)	$	(12,974,799	)
Net loss - Non-controlling interest		(568,195	)		(400,847	)
Net loss attributable to Heat Biologics, Inc.	$	(11,841,671	)	$	(12,573,952	)
Weighted-average number of common shares used in net loss per share attributable to common stockholders —basic and diluted		3,845,342			1,758,621
Net loss per share attributable to Heat Biologics, Inc —basic and diluted	$	(3.08	)	$	(7.15	)

The following potentially dilutive securities were excluded from the calculation of diluted net loss per share due to their anti-dilutive effect:

	For the years ended December 31,
	2017		2016
Outstanding stock options		266,810		113,672
Unvested restricted stock units		21,779		5,625
Outstanding common stock warrants		310,397		310,397